In summary, the authors present encouraging data for the potential clinical value of tissue hemodynamic assessment with dynamic contrast-enhanced CT. These results are robust enough to warrant an optimistic forecast that further refinements of this technique will produce a useful tool for improving the diagnosis of tumors and the monitoring of cancer therapy outcomes.
